(R)-2-(1-(((9H-Fluoren-9-yl)methoxy)carbonyl)pyrrolidin-2-yl)acetic acid, 95.0%, 10g

Oxion Inverso OX.2053-PLPH with LWD Plan phase 10x/20x/40x objectives and XY cross table

3,6-Dibromo-9-(4-dodecyloxyphenyl)-9H-carbazole>97.0%(HPLC)(N)1g

Ethyl 6-[bis(tert-butoxycarbonyl)amino]nicotinate, 95.0%, 1g

D-Sorbitol, min. 98%, for biochemistry, 5 kg, plastic packaging.

cis-3,4-Difluoropyrrolidine hydrochloride, 95.0%, 5g

3-(Trifluoromethyl)phenylboronic Acid (contains varying amounts of Anhydride)5g

Orlistat>97.0%(HPLC)(N)1g

(4,5-Dichloro-1H-imidazol-2-yl)methanol, 97%, 1g

Cyclohexyldiphenylphosphine>97.0%(GC)5g

TERT-BUTYL 3-(6-FLUOROPYRIDIN-3-YL)AZETIDINE-1-CARBOXYLATE, 95.0%, 250mg

(S)-4-BROMO-2,3-DIHYDRO-1H-INDEN-1-AMINE, 95.0%, 5g

1H,1H,2H,2H-Nonafluoro-1-hexanol>97.0%(GC)25g